212 related articles for article (PubMed ID: 29486578)
21. Metadherin promotes hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition.
Zhu K; Dai Z; Pan Q; Wang Z; Yang GH; Yu L; Ding ZB; Shi GM; Ke AW; Yang XR; Tao ZH; Zhao YM; Qin Y; Zeng HY; Tang ZY; Fan J; Zhou J
Clin Cancer Res; 2011 Dec; 17(23):7294-302. PubMed ID: 21976539
[TBL] [Abstract][Full Text] [Related]
22. Type IIA topoisomerase (TOP2A) triggers epithelial-mesenchymal transition and facilitates HCC progression by regulating Snail expression.
Dong Y; Sun X; Zhang K; He X; Zhang Q; Song H; Xu M; Lu H; Ren R
Bioengineered; 2021 Dec; 12(2):12967-12979. PubMed ID: 34939898
[TBL] [Abstract][Full Text] [Related]
23. Plantamajoside inhibits the proliferation and epithelial-to-mesenchymal transition in hepatocellular carcinoma cells via modulating hypoxia-inducible factor-1α-dependent gene expression.
Yin W; Xu J; Li C; Dai X; Wu T; Wen J
Cell Biol Int; 2020 Aug; 44(8):1616-1627. PubMed ID: 32239594
[TBL] [Abstract][Full Text] [Related]
24. AP-2β inhibits hepatocellular carcinoma invasion and metastasis through Slug and Snail to suppress epithelial-mesenchymal transition.
Yang L; Qiu J; Xiao Y; Hu X; Liu Q; Chen L; Huang W; Li X; Li L; Zhang J; Ding X; Xiang S
Theranostics; 2018; 8(13):3707-3721. PubMed ID: 30026878
[TBL] [Abstract][Full Text] [Related]
25. The role of XBP1s in the metastasis and prognosis of hepatocellular carcinoma.
Wu S; Du R; Gao C; Kang J; Wen J; Sun T
Biochem Biophys Res Commun; 2018 Jun; 500(3):530-537. PubMed ID: 29627568
[TBL] [Abstract][Full Text] [Related]
26. CCR7 preservation via histone deacetylase inhibition promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells.
Yang L; Chang Y; Cao P
Exp Cell Res; 2018 Oct; 371(1):231-237. PubMed ID: 30107147
[TBL] [Abstract][Full Text] [Related]
27. Long non-coding RNA NRON is downregulated in HCC and suppresses tumour cell proliferation and metastasis.
Yao Z; Xiong Z; Li R; Liang H; Jia C; Deng M
Biomed Pharmacother; 2018 Aug; 104():102-109. PubMed ID: 29772429
[TBL] [Abstract][Full Text] [Related]
28. G9a and histone deacetylases are crucial for Snail2-mediated E-cadherin repression and metastasis in hepatocellular carcinoma.
Hu Y; Zheng Y; Dai M; Wang X; Wu J; Yu B; Zhang H; Cui Y; Kong W; Wu H; Yu X
Cancer Sci; 2019 Nov; 110(11):3442-3452. PubMed ID: 31432592
[TBL] [Abstract][Full Text] [Related]
29. Cinobufacini inhibits epithelial-mesenchymal transition of human hepatocellular carcinoma cells through c-Met/ERK signaling pathway.
Qi F; Wang J; Zhao L; Cai P; Tang W; Wang Z
Biosci Trends; 2018 Jul; 12(3):291-297. PubMed ID: 29794405
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of CSN6 promotes the epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma.
Xu M; Zhen L; Lin L; Wu K; Wang Y; Cai X
Clin Res Hepatol Gastroenterol; 2020 Jun; 44(3):340-348. PubMed ID: 31422034
[TBL] [Abstract][Full Text] [Related]
31. Oviductus ranae protein hydrolysate (ORPH) inhibits the growth, metastasis and glycolysis of HCC by targeting miR-491-5p/PKM2 axis.
Xu Q; Dou C; Liu X; Yang L; Ni C; Wang J; Guo Y; Yang W; Tong X; Huang D
Biomed Pharmacother; 2018 Nov; 107():1692-1704. PubMed ID: 30257387
[TBL] [Abstract][Full Text] [Related]
32. HCC-derived exosomes elicit HCC progression and recurrence by epithelial-mesenchymal transition through MAPK/ERK signalling pathway.
Chen L; Guo P; He Y; Chen Z; Chen L; Luo Y; Qi L; Liu Y; Wu Q; Cui Y; Fang F; Zhang X; Song T; Guo H
Cell Death Dis; 2018 May; 9(5):513. PubMed ID: 29725020
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-30b Suppresses Epithelial-Mesenchymal Transition and Metastasis of Hepatoma Cells.
Sun X; Zhao S; Li H; Chang H; Huang Z; Ding Z; Dong L; Chen J; Zang Y; Zhang J
J Cell Physiol; 2017 Mar; 232(3):625-634. PubMed ID: 27333771
[TBL] [Abstract][Full Text] [Related]
34. Metformin sensitizes sorafenib to inhibit postoperative recurrence and metastasis of hepatocellular carcinoma in orthotopic mouse models.
You A; Cao M; Guo Z; Zuo B; Gao J; Zhou H; Li H; Cui Y; Fang F; Zhang W; Song T; Li Q; Zhu X; Yin H; Sun H; Zhang T
J Hematol Oncol; 2016 Mar; 9():20. PubMed ID: 26957312
[TBL] [Abstract][Full Text] [Related]
35. RANKL promotes migration and invasion of hepatocellular carcinoma cells via NF-κB-mediated epithelial-mesenchymal transition.
Song FN; Duan M; Liu LZ; Wang ZC; Shi JY; Yang LX; Zhou J; Fan J; Gao Q; Wang XY
PLoS One; 2014; 9(9):e108507. PubMed ID: 25268581
[TBL] [Abstract][Full Text] [Related]
36. Decreased TIP30 promotes Snail-mediated epithelial-mesenchymal transition and tumor-initiating properties in hepatocellular carcinoma.
Zhu M; Yin F; Fan X; Jing W; Chen R; Liu L; Zhang L; Liu Y; Liang Y; Bu F; Tong X; Zheng H; Zhao J; Guo Y
Oncogene; 2015 Mar; 34(11):1420-31. PubMed ID: 24681951
[TBL] [Abstract][Full Text] [Related]
37. I
Wu L; Sun B; Lin X; Liu C; Qian H; Chen L; Yang Y; Shen F; Su C
Genes Cells; 2018 Jan; 23(1):35-45. PubMed ID: 29210217
[TBL] [Abstract][Full Text] [Related]
38. Apigenin inhibits NF-κB and snail signaling, EMT and metastasis in human hepatocellular carcinoma.
Qin Y; Zhao D; Zhou HG; Wang XH; Zhong WL; Chen S; Gu WG; Wang W; Zhang CH; Liu YR; Liu HJ; Zhang Q; Guo YQ; Sun T; Yang C
Oncotarget; 2016 Jul; 7(27):41421-41431. PubMed ID: 27203387
[TBL] [Abstract][Full Text] [Related]
39. Cinobufotalin inhibits the epithelial-mesenchymal transition of hepatocellular carcinoma cells through down-regulate β-catenin in vitro and in vivo.
Li W; Pei S; Zhang X; Qi D; Zhang W; Dou Y; Yang R; Yao X; Zhang Z; Xie S; Fang D; Sun H
Eur J Pharmacol; 2022 May; 922():174886. PubMed ID: 35292248
[TBL] [Abstract][Full Text] [Related]
40. Doxycycline as an inhibitor of the epithelial-to-mesenchymal transition and vasculogenic mimicry in hepatocellular carcinoma.
Meng J; Sun B; Zhao X; Zhang D; Zhao X; Gu Q; Dong X; Zhao N; Liu P; Liu Y
Mol Cancer Ther; 2014 Dec; 13(12):3107-22. PubMed ID: 25277383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
